Bone morphogenetic protein–associated complications in pediatric spinal fusion in the early postoperative period: an analysis of 4658 patients and review of the literature

Complications associated with recombinant human bone morphogenetic protein use in pediatric craniocervical arthrodesis

(2016) Timothy E. Lindley et al.   Journal of Neurosurgery-Pediatrics

Rh-BMP-2 for L5–S1 arthrodesis in long fusions to the pelvis for neuromuscular spinal deformity in the pediatric age group: analysis of 11 patients

(2013) Loyola V. Gressot et al.   CHILDS NERVOUS SYSTEM

Cancer Risk After Use of Recombinant Bone Morphogenetic Protein-2 for Spinal Arthrodesis

(2013) Eugene J Carragee et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

Factors Associated with Use of Bone Morphogenetic Protein During Pediatric Spinal Fusion Surgery

(2013) Amit Jain et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

Cancer After Spinal Fusion

(2013) Shivanand P. Lad et al.   NEUROSURGERY

Risk of Cancer After Lumbar Fusion Surgery With Recombinant Human Bone Morphogenic Protein-2 (rh-BMP-2)

(2013) Gregory S. Cooper et al.   SPINE

Off-Label Use of Bone Morphogenetic Proteins in Pediatric Spinal Arthrodesis

(2012) Emily Dodwell et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Recombinant Human Bone Morphogenetic Protein-2 as an Adjunct for Spine Fusion in a Pediatric Population

(2012) Muhammad M. Abd-El-Barr et al.   PEDIATRIC NEUROSURGERY

Complications Associated With the Use of Bone Morphogenetic Protein in Pediatric Patients

(2011) Matthew E. Oetgen et al.   JOURNAL OF PEDIATRIC ORTHOPAEDICS

Does Bone Morphogenetic Protein Increasethe Incidence of Perioperative Complicationsin Spinal Fusion?

(2011) Brian J. Williams et al.   SPINE

A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned

(2011) Eugene J. Carragee et al.   Spine Journal

Bone Morphogenetic Proteins and Cancer

(2010) Jayesh P. Thawani et al.   NEUROSURGERY

Routine Use of Recombinant Human Bone Morphogenetic Protein-2 in Posterior Fusions of the Pediatric Spine: Safety Profile and Efficacy in the Early Postoperative Period

(2010) Daniel K Fahim et al.   NEUROSURGERY

Off-Label Use of Bone Morphogenetic Proteins in the United States Using Administrative Data

(2010) Kevin L. Ong et al.   SPINE

Complications With Recombinant Human Bone Morphogenic Protein-2 in Posterolateral Spine Fusion

(2010) Steven D. Glassman et al.   SPINE

Prevalence, Complications, and Hospital Charges Associated With Use of Bone-Morphogenetic Proteins in Spinal Fusion Procedures

(2009) Kevin S. Cahill   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION